Infectious Disease Therapeutics
MerLion Pharmaceuticals GmbH: Products & infrastructure
MerLion Pharmaceuticals GmbH has 8 clinical trials on record, 0 under way.
Data updated Nov 20, 2026 · Back to the company report
Products
MerLion Pharmaceuticals GmbH has 8 clinical trials on record, 0 under way.
8clinical trials
Clinical trialsthe studies it sponsors or works on, per ClinicalTrials.gov
Finafloxacin for the Treatment of cUTI and/or Acute Pyelonephritis
phase 2 · completed · 225 participants · Urinary Tract Infections; Acute Pyelonephritis
Dec 2012
Pharmacokinetic Profile in Plasma and Epithelial Lining Fluid of Finafloxacin
phase 1 · completed · 18 participants · Safety and Tolerability
Jan 2012
Safety and Tolerability of Single and Multiple Intravenous Doses of Finafloxacin in Healthy Subjects
phase 1 · completed · 58 participants · Healthy
Sep 2010
Effect of Age and Gender on the PK and Tolerability of Finafloxacin
phase 1 · completed · 40 participants · Pharmacokinetic and Tolerability of Finafloxacin
Feb 2010
Finafloxacin 300 mg Twice a Day (b.i.d.) Versus Ciprofloxacin 250 mg Twice a Day (b.i.d) in Patients With Lower Uncompl…
phase 2 · completed · 36 participants · Urinary Tract Infections
Oct 2008
Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected Patients
phase 2 · completed · 30 participants · Gram-Negative Bacterial Infections; Helicobacter Infections; Dyspepsia
Sep 2008
First Time in Man Study of Finafloxacin Hydrochloride
phase 1 · completed · 95 participants · Helicobacter Infections; Urinary Tract Infection
Aug 2007
First Time in Man Trial for Friulimicin B
phase 1 · stopped or withdrawn · 31 participants · Community Acquired Pneumonia; Staphylococcal Skin Infections
Jun 2007
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
